Leap Therapeutics, Inc. (Nasdaq: LPTX) has secured $58.88 million via a private investment in public equity (PIPE) round to launch a digital asset treasury.
The October 6 announcement confirmed that the round was led by Winklevoss Capital, the family office of Gemini co-founders Tyler and Cameron Winklevoss.
The firm will provide both financial support and strategic guidance as Leap develops its blockchain-based treasury approach.
The deal involves the issuance of common shares and warrants with an aggregate exercise price of $0.61439 per unit, with closing expected around October 8.
Governance changes include expanding Leap’s board to 12 members, with Winklevoss Capital gaining two nominations, one serving as board chair.
While most funds will go toward the digital asset treasury, a portion supports Leap’s immuno-oncology pipeline, including sirexatamab and FL-501. Leap will present new clinical data later this month. The company said further information on its crypto treasury plans will be released soon.
You need to login in order to Like
Leave a comment